Vesalius Biocapital offers venture capital
to young European innovative life science companies
GenKyoTex is a product-driven biopharmaceutical company dedicated to the development of innovative therapeutics blocking the source of production of oxygen radicals in a specific manner to meet unmet medical need.
Therapeutics
Switzerland / France
Investing phase